Literature DB >> 29453861

Virus-Like Particle Engineering: From Rational Design to Versatile Applications.

Xuanwei Ding1,2, Dong Liu1, George Booth3, Wei Gao1,2, Yuan Lu1.   

Abstract

As mimicking natural virus structures, virus-like particles (VLPs) have evolved to become a widely accepted technology used for humans which are safe, highly efficacious, and profitable. Several remarkable advantages have been achieved to revolutionize the molecule delivery for diverse applications in nanotechnology, biotechnology, and medicine. Here, the rational structure design, manufacturing process, functionalization strategy, and emerging applications of VLPs is reviewed. The situation and challenges in the VLP engineering, the key development orientation, and future applications have been discussed. To develop a good VLP design concept, the virus/VLP-host interactions need to be examined and the screening methods of the VLP stabilization factors need to be established. The functionalization toolbox can be expanded to fabricate smart, robust, and multifunctional VLPs. Novel robust VLP manufacturing platforms are required to deliver vaccines in resource-poor regions with a significant reduction in the production time and cost. The future applications of VLPs are always driven by the development of emerging technologies and new requirements of modern life.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  biomaterials; inside encapsulation; nanoparticle; surface bioconjugation; virus-like particle

Mesh:

Substances:

Year:  2018        PMID: 29453861     DOI: 10.1002/biot.201700324

Source DB:  PubMed          Journal:  Biotechnol J        ISSN: 1860-6768            Impact factor:   4.677


  16 in total

Review 1.  51 years in of Chikungunya clinical vaccine development: A historical perspective.

Authors:  Arturo Reyes-Sandoval
Journal:  Hum Vaccin Immunother       Date:  2019-04-02       Impact factor: 3.452

2.  Engineering a Virus-like Particle to Display Peptide Insertions Using an Apparent Fitness Landscape.

Authors:  Stephanie A Robinson; Emily C Hartman; Bon C Ikwuagwu; Matthew B Francis; Danielle Tullman-Ercek
Journal:  Biomacromolecules       Date:  2020-09-03       Impact factor: 6.988

3.  Formation of Virus-Like Particles of the Dengue Virus Serotype 2 Expressed in Silkworm Larvae.

Authors:  Doddy Irawan Setyo Utomo; Ichikawa Hirono; Tatsuya Kato; Enoch Y Park
Journal:  Mol Biotechnol       Date:  2019-11       Impact factor: 2.695

4.  Inositol Hexakisphosphate (IP6) Accelerates Immature HIV-1 Gag Protein Assembly toward Kinetically Trapped Morphologies.

Authors:  Alexander J Pak; Manish Gupta; Mark Yeager; Gregory A Voth
Journal:  J Am Chem Soc       Date:  2022-06-06       Impact factor: 16.383

Review 5.  The pharmacology of plant virus nanoparticles.

Authors:  Christian Isalomboto Nkanga; Nicole F Steinmetz
Journal:  Virology       Date:  2021-01-28       Impact factor: 3.616

6.  Asparaginase-Phage P22 Nanoreactors: Toward a Biobetter Development for Acute Lymphoblastic Leukemia Treatment.

Authors:  Cristina Díaz-Barriga; Francisca Villanueva-Flores; Katrin Quester; Andrés Zárate-Romero; Ruben Dario Cadena-Nava; Alejandro Huerta-Saquero
Journal:  Pharmaceutics       Date:  2021-04-22       Impact factor: 6.321

Review 7.  Prospects on the Use of Schizochytrium sp. to Develop Oral Vaccines.

Authors:  Abel Ramos-Vega; Sergio Rosales-Mendoza; Bernardo Bañuelos-Hernández; Carlos Angulo
Journal:  Front Microbiol       Date:  2018-10-25       Impact factor: 5.640

8.  Role of metallic core for the stability of virus-like particles in strongly coupled electrostatics.

Authors:  Leili Javidpour; Anže Lošdorfer Božič; Rudolf Podgornik; Ali Naji
Journal:  Sci Rep       Date:  2019-03-07       Impact factor: 4.379

9.  Self-Assembly of Tail Tube Protein of Bacteriophage vB_EcoS_NBD2 into Extremely Long Polytubes in E. coli and S. cerevisiae.

Authors:  Aliona Špakova; Eugenijus Šimoliūnas; Raminta Batiuškaitė; Simonas Pajeda; Rolandas Meškys; Rasa Petraitytė-Burneikienė
Journal:  Viruses       Date:  2019-03-01       Impact factor: 5.048

10.  Assembly of Capsids from Hepatitis B Virus Core Protein Progresses through Highly Populated Intermediates in the Presence and Absence of RNA.

Authors:  Ryan C Oliver; Wojciech Potrzebowski; Seyed Morteza Najibi; Martin Nors Pedersen; Lise Arleth; Najet Mahmoudi; Ingemar André
Journal:  ACS Nano       Date:  2020-08-04       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.